Exozymes Cash Flow Statement (2023-2024) | EXOZ

Cash Flow Statement Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024
Operating Activities
Net Income (Quarter) -0.52M-1.06M-1.01M-1.36M-1.66M-1.84M
Depreciation and Depletion (Quarter) 0.05M0.06M0.06M0.07M0.07M0.07M
Share-based Compensation (Quarter) 0.11M0.14M0.35M0.32M0.32M
Gains from Investment Securities (Quarter) 0.05M1.04M1.75M
Non-cash Items (Quarter) 0.29M0.32M0.70M0.38M4.87M
Cash from Operations (Quarter) -0.78M0.28M-2.54M-0.54M-5.71M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) -0.01M-0.01M-0.01M-0.01M
Depreciation & Amortization (CF) (Quarter) 0.05M0.06M0.06M0.07M0.07M0.07M
Change in Working Capital
Change in Receivables (Quarter) 0.21M0.23M0.04M-0.59M0.18M
Change in Account Payables (Quarter) 0.01M1.32M-1.22M-0.10M-4.25M
Change in Accured Expenses (Quarter) 0.40M0.05M-0.41M0.27M0.30M
Change in Taxes (Quarter) -0.00M-0.04M
Investing Activities
Capital Expenditures (Quarter) 0.11M0.15M0.04M0.21M
Cash from Investing Activities (Quarter) -0.11M-0.14M-0.04M0.03M-0.21M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt Issuances (Quarter) -0.32M0.75M
Short-Term Debt repayments (Quarter) 0.58M0.75M
Misc.
Cash from Financing Activities (Quarter) 0.48M-0.09M2.62M0.59M15.40M
Change in Cash (Quarter) -0.41M0.05M0.04M0.08M9.49M
Free Cash Flow (Quarter) -0.89M0.13M-2.58M-0.54M-5.92M
Net Cash Flow (Quarter) -0.41M0.05M0.04M0.08M9.49M